Cited by 50Parkinson's Disease Mechanisms and TreatmentsNeurological disorders and treatmentsNuclear Receptors and Signaling

POLG1 in idiopathic Parkinson disease

Open access
Tiangyou, W., Hudson, G., Ghezzi, D., Ferrari, G., Zeviani, M., Burn, D. J., Chinnery, P. F.·2006·Neurology

Abstract

We studied POLG1 in 140 UK patients with idiopathic Parkinson disease (PD) and 279 Italian patients with PD and compared them to a UK control group (n = 207) and an Italian control group (n = 285). Our observations do not support a role for common POLG1 genetic variants in PD and indicate that dominant POLG1 mutations are a rare cause of parkinsonism in the general population.

Integrity signals

Registry

Crossref · 10.1212/01.wnl.0000238963.07425.d5

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Tiangyou, W., Hudson, G., Ghezzi, D., Ferrari, G., Zeviani, M., Burn, D. J., & Chinnery, P. F.
Affiliations
Newcastle University (GB)
Venue
Neurology
Published
2006-11-14
Volume
67
Issue
9
Pages
1698-1700
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2123839204
Cited by
50
References
10
Citations by year
2024: 1 · 2023: 3 · 2022: 2 · 2021: 2 · 2020: 2 · 2017: 1 · 2016: 1 · 2015: 1 · 2014: 1 · 2013: 2 · 2012: 7
FWCI
3.44
Type
journal article
Language
en
Open access
Locations
  • Neurology (publishedVersion)
  • PubMed (publishedVersion)
  • Padua Research Archive (University of Padova) (submittedVersion)
  • Newcastle University ePrints (Newcastle Univesity)
Funders
Fondazione Telethon
Topics
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Health Sciences › Medicine › Neurology › Neurological disorders and treatments
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nuclear Receptors and Signaling
Keywords
POLG1, idiopathic Parkinson's disease, parkinsonism, genetic variants, dominant mutations, DNA polymerase gamma, genetic susceptibility
MeSH terms
DNA Polymerase gamma, Aged, DNA Mutational Analysis, DNA-Directed DNA Polymerase, Exons, Female, Gene Frequency, Genetic Markers, Genetic Testing, Genotype, United Kingdom, Humans, Italy, Male, Middle Aged, Mutation, Parkinson Disease, Polymorphism, Genetic, Genetic Variation, Cohort Studies, Genetic Predisposition to Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review